References:
  1. Schoene K, Arya A, Grashoff F, et al. Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial. Europace. 2020;22(10):1487-1494.
  2. Chen S, Schmidt B, Seeger A, et al. Catheter ablation of atrial fibrillation using ablation indexguided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II). Heart Rhythm. 2020;17(11):1833-1840.
  3. Meininghaus DG, Blembel K, Waniek C, et al. Temperature monitoring and temperature-driven irrigated radiofrequency energy titration do not prevent thermally induced esophageal lesions in pulmonary vein isolation: A randomized study controlled by esophagoscopy before and after catheter ablation. Heart Rhythm. 2021 DOI: 10.1016/j.hrthm.2021.02.003.
  4. Clark B, Alvi N, Hanks J, Suprenant B. A Pilot Study of an Esophageal Cooling Device During Radiofrequency Ablation for Atrial Fibrillation. medRxiv. 2020:2020.2001.2027.20019026.
  5. Tschabrunn CM, Attalla S, Salas J, et al. Active esophageal cooling for the prevention of thermal injury during atrial fibrillation ablation: a randomized controlled pilot study. J Interv Card Electrophysiol. 2021 DOI: 10.1007/s10840-021-00960-w.
  6. Leung LWM, Bajpai A, Zuberi Z, et al. Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study. Europace. 2021;23(2):205-215.